Nestle to Buy Pfizer's Infant Nutrition Business
Nestlé SA's $10 billion bid for Pfizer Inc.'s baby food business aims to strengthen its footprint in China, a major market where it doesn't lead, unlike many others. The WSJ's Jake Lee speaks to Isabella Steger about the deal
Related Videos
Most Popular Videos
Latest Videos
Most Active by Volume:
| Company | Last Sale | Change Net / % |
|---|---|---|
| BAC | $ 13.44 |
0.07 0.52%
|
| F | $ 14.95 |
0.10 0.66%
|
| CLWR | $ 3.40 |
0.14 4.29%
|
| SIRI | $ 3.515 |
0.02 0.43%
|
| MSFT | $ 34.85 |
0.23 0.66%
|
| CSCO | $ 24.01 |
0.07 0.27%
|
| MRK | $ 47.33 |
2.12 4.69%
|
| PFE | $ 28.78 |
0.08 0.28%
|
Latest News Headlines
PGT Announces Increase in Size and Pricing of Secondary Offering 8:20PM ET - GlobeNewswire
Chevron Nears Sale of Egypt, Pakistan Downstream Assets: Sources- Reuters 8:07PM ET - Dow Jones Business News
Entergy's Palisades Nuclear Plant Likely to Stay Closed Until at Least Early Summer -Kalamazoo Gaze 7:55PM ET - Dow Jones Business News
2nd UPDATE: Intuit 3rd-Quarter Net Rises 12% on Small-Business Strength 6:45PM ET - Dow Jones Business News
Rosetta Resources Inc. to Present at Upcoming Investor Conferences 6:40PM ET - GlobeNewswire

0.52%
4.29%